Eviden coordonne le projet CYDERCO pour le Centre européen de compétences en cybersécurité (ECCC)
28. Oktober 2024 05:00 ET
|
Atos International
Communiqué de presse Eviden coordonne le projet CYDERCO pour le Centre européen de compétences en cybersécurité (ECCC) Un projet de 3 ans cofinancé par la Commission européenne pour renforcer...
Eviden manages coordination of CYDERCO project for the European Cybersecurity Competence Center (ECCC)
28. Oktober 2024 05:00 ET
|
Atos International
Press Release Eviden manages coordination of CYDERCO project funded by the European Cybersecurity Competence Center (ECCC) 3-year project co-funded by the European Commission aims to strengthen...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron JN.1 angepassten COVID-19-Impfstoff in der Europäischen Union
27. Juni 2024 10:30 ET
|
BioNTech SE
Der aktualisierte COVID-19-Impfstoff ist auf die Omikron JN.1-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen und...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
27. Juni 2024 10:30 ET
|
BioNTech SE
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical and...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron XBB.1.5 angepassten COVID-19-Impfstoff in der Europäischen Union
30. August 2023 10:00 ET
|
BioNTech SE
Der aktualisierte COVID-19-Impfstoff ist auf die Omikron XBB.1.5-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen Daten, die...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
30. August 2023 10:00 ET
|
BioNTech SE
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical data...
SPEC Forms International Standards Group
27. September 2022 04:00 ET
|
SPEC
GAINESVILLE, Va., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The Standard Performance Evaluation Corp. (SPEC) announced the formation of the International Standards Group (ISG) to collaborate with...
Helsinn announces European Commission approval of the liquid formulation of AKYNZEO® (fosnetupitant/palonosetron)
02. Dezember 2021 04:30 ET
|
Helsinn Healthcare S.A.
Helsinn announces European Commission approval of the liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) Lugano, Switzerland, December 2, 2021 – Helsinn Group, a fully integrated, global...
Pomilio Blumm wins record €200m EU tender for communications
26. November 2021 07:41 ET
|
Pomilio Blumm
ROME, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Pomilio Blumm has won a tender issued by the European Commission for €200 million over four years. The agency will be responsible for the design and...
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
25. November 2021 07:30 ET
|
BioNTech SE
NEW YORK and MAINZ, Germany, November 25, 2021—Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use...